A prospective evaluation of a variant of biliopancreatic diversion with Roux-en-Y reconstruction in mega-obese patients (BMI≥70 kg/m2)

Obesity Surgery

Volumn 18, Issue 7, 2008, Pages 803-809

  Spyropoulos, Charalambos ^a   Bakellas, George ^a   Skroubis, George ^a   Kehagias, Ioannis ^a   Mead, Nancy ^b   Vagenas, Konstantinos ^a   Kalfarentzos, Fotis ^a,b  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Biliopancreatic diversion; Complications; Mega obese; Morbidity; Mortality

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CYANOCOBALAMIN; ENOXAPARIN; FERRITIN; FOLIC ACID; GLUCOSE; HEMOGLOBIN; LIPID; MAGNESIUM; PHOSPHATE;

ACUTE KIDNEY FAILURE; ADULT; ANASTOMOSIS LEAKAGE; ANEMIA; ANOREXIA; ARTICLE; BILIOPANCREATIC BYPASS; BODY MASS; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DIETARY INTAKE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GASTROJEJUNOSTOMY; GLUCOSE METABOLISM; HUMAN; HYPOALBUMINEMIA; INCISIONAL HERNIA; LIPID METABOLISM; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MINERAL METABOLISM; MORBID OBESITY; MORBIDITY; MORTALITY; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SMALL INTESTINE OBSTRUCTION; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ADULT; BILIOPANCREATIC DIVERSION; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 46949096660     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-008-9449-3     Document Type: Article

References (18)

1. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547-59.
2. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-93.
3. Brolin RE, LaMarca LB, Kenler HA, et al. Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg. 2002;6:195-203.
4. Fernandez AZ Jr, DeMaria EJ, Tichansky DS, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239:698-702.
5. Benotti PN, Wood GC, Rodriguez H, et al. Perioperative outcomes and risk factors in gastric surgery for morbid obesity: a 9-year experience. Surgery. 2006;139:340-6.
6. 2: a comparative analysis of 825 procedures. J Gastrointest Surg. 2005;9:44-52.
7. Sarr MG, Felty CL, Hilmer DM, et al. Technical and practical considerations involved in operations on patients weighing more than 270 kg. Arch Surg. 1995;130:102-5.
8. Kreitz K, Rovito PF. Laparoscopic Roux-en-Y gastric bypass in the "megaobese". Arch Surg. 2003;138:707-9.
9. Kalfarentzos F, Papadoulas S, Skroubis G, et al. Prospective evaluation of biliopancreatic diversion with Roux-en-Y gastric bypass in the super obese. J Gastrointest Surg. 2004;8:479-88.
10. Bloomston M, Zervos EE, Camps MA, et al. Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter? Obes Surg. 1997;7:414-9.
11. DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007;3:134-40.
12. Demaria EJ, Murr M, Byrne TK, et al. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg. 2007;246:578-84.
13. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion: two decades of experience. In: Deitel M, Cowan GSM, editors. Update: surgery for the morbidly obese patient. Toronto: FD Communications Inc. 2000:227-58.
14. Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007;17:176-84.
15. Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI>or=50). Obes Surg. 2005;15:612-7.
16. Scopinaro N, Gianetta E, Friedman D, et al. Evolution of biliopancreatic bypass. Clin Nutr. 5(Suppl) 1986:137-46.
17. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936-46.
18. Spyropoulos C, Katsakoulis E, Mead N, et al. Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surg Obes Relat Dis. 2007;3:78-83.